Elevance Health, Inc. (ELV) stock
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3011% below fair value
$400.84−33.09 (-7.63%)
Close on Nov 18, 2026Market cap $86.60BP/E 17.1Yield –
Elevance Health r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Elevance Health
Elevance Health has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?